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Abstract 
The importance of environmental contamination in the spread of HAI has generated 
a need for high performance disinfectants. Currently chlorine based disinfectants are 
the products of choice, a position reflected in UK guidance. The aim of this research 
was to evaluate a peracetic acid (PAA) generating disinfectant to determine if it 
provided a realistic alternative to commonly used chlorine based disinfectants. The 
European standards framework was employed in this study and enhanced where 
appropriate by reducing the contact times, increasing the organic and microbial 
challenge, and changing the organisms involved. When tested against bacteria and 
spores PAA provided similar or better performance than currently employed levels of 
chlorine. This was particularly the case in the presence of an organic challenge or 
dried surface contamination. The chlorine disinfectants only demonstrated superior 
performance in the case of fungal spores. These results suggest that PAA 
generating products provide an effective alternative to chlorine based products up to 
10,000 ppm free available chlorine. These products have superior performance in 
situations with spore borne, surface contamination and high organic challenge. In 
cases where filamentous fungi are a concern, high levels of PAA (>5000 ppm) would 
be required to match the performance of chlorine based disinfectants.  
Introduction 
Environmental contamination has been implicated in the spread of healthcare 
associated infections (HAI)(Dancer and Carling, 2010, Wang et al., 2010, Weber et 
al., 2010, Carling and Bartley, 2010), consequently environmental cleaning can 
contribute significantly to the control of HAI(Dancer, 2009, Otter et al., 2011, Dancer 
et al., 2009). Of the microorganisms associated with HAI, Clostridium difficile (C. 
difficile)(Malamou-Ladas et al., 1983, Kim et al., 1981) represents the most 
significant disinfection challenge due to: the innate disinfection resistance of C. 
difficile spores (Tumah, 2009, Maillard, 2011), their environmental 
persistence(Kramer et al., 2006), the large numbers of spores excreted(Mulligan et 
al., 1979) and their low infective dose(Sambol et al., 2001). The requirement for 
disinfectants able to inactivate C. difficile spores, and the  limited number of 
sporicides (Tumah, 2009, Lambert, 2004), has resulted in the domination of chlorine 
based products (Vohra and Poxton, 2011, Fraise, 2011). This dominance is reflected 
in UK guidance (DoH and HPA, 2009, Pratt et al., 2007) where products delivering 
1,000ppm free available chlorine (FAC) are recommended for cleaning associated 
with patients with C. difficile infections (CDI), in the presence of blood 10,000 ppm 
FAC is recommended (DoH, 1998). Chlorine based products have disadvantages 
including: respiratory irritation (Fraise, 2011), reduced activity in the presence of 
organic matter (McDonnell and Russell, 1999, Maillard, 2011) and incompatibility 
with microfiber cloths (NPSA, 2009, Gant et al., 2010). There is also evidence that 
chlorine base disinfectants have limited efficacy against environmental C. difficile 
contamination (Ali et al., 2011, Goldenberg et al., 2012).  
Peroxygen compounds potentially provide a viable alternative to chlorine, given their 
broad spectrum biocidal activity (McDonnell and Russell, 1999, Fraise et al., 2004). 
Peroxygen based disinfectants are generally employed in instrument 
decontamination (Hernández et al., 2003a, Hernández et al., 2003b, Vizcaino-
Alcaide et al., 2003), and have received limited attention as environmental 
disinfectants (Carter and Barry, 2011, Speight et al., 2011) apart from their use in 
wipes(Carter and Barry, 2011). However, peroxygen compound such as peracetic 
acid (PAA) can be easily generated through the aqueous reaction of 
tetraacetylethylenediamine (TAED) and a peroxide generator (Pan et al., 1999, 
Davies and Deary, 1991).  
The objective of this study was to evaluate the disinfection capabilities of a PAA 
generating powder blend delivered in a dissolving sachet. The evaluation was 
performed by comparison with commercial sodium dichloroisocyanurate (NaDCC) 
tablets generating the two recommended levels of FAC, (1000 ppm (DoH and HPA, 
2009, Pratt et al., 2007) and 10,000 ppm(DoH, 1998)). NaDCC in contact with water 
generates free FAC via hypochlorous acid, with a reservoir of FAC being maintained 
by solution phase, chlorinated isocyanurates (Clasen and Edmondson, 2006). This 
reservoir of FAC generated by NaDCC contributes to its improved performance over 
and above hypochlorite based products (Fawley et al., 2007). A NaDCC based 
chlorine generating system was chosen for this investigation due to its proven 
advantages over hypochlorite (Fawley et al., 2007) and its common usage in the 
NHS, e.g. (Bailey, 2009, Bloomfield, 2011, Wirral, 2010).This comparison employed 
the European standard disinfection tests(BSI, 2006, Humphreys, 2011) modified to 
increase the disinfection demand posed.  
Methods 
Testing Strategy 
The European standards framework(BSI, 2006) for the testing of disinfectants was 
used as a basis for this investigation. The tests employed are all commonly used to 
verify the effectiveness of disinfectants employed in healthcare settings. Two testing 
approaches were employed; firstly suspension tests to determine basic bactericidal, 
(BS EN 1276(BSI, 1997)), fungicidal (BS EN 1650 (BSI, 2008)) and sporicidal (BS 
EN 13704 (BSI, 2002)) activity and secondly, surface tests (BS EN 13697(BSI, 
2001)) to determine the surface bactericidal and sporicidal activity of the two 
disinfectants. In order to pass these standard tests a disinfectant has to generate the 
required log reduction in the specified contact time in the presence of the specified 
interfering substance (Table 1). The organisms specified by the standards (BSI, 
2006) are chosen to be representative of a wide range of pathogenic organisms 
relevant to healthcare settings. In suspension tests, a suspension of organisms or 
spores is mixed with a sample of interfering substance (see below) and then with the 
disinfectant under test. The mixture is then incubated at 20oC for the specified 
contact time (Table 1), following incubation a sample of the test mixture is 
transferred to a neutralisation solution which stops the action of the disinfectant and 
preserves the contact time. Following neutralisation the number of surviving 
organisms or spores is determined employing the media and incubation conditions 
specified in the relevant standard.  The tests include a range of validations including 
a neutralisation test which ensure the neutralisation solution is effective.  
In the surface test BS EN 13697 (BSI, 2001) a suspension of bacteria or spores is 
mixed with a sample of interfering substance (see below) and then dried onto a 
stainless steel surface prior to the application of the disinfectant under test. Following 
the specified contact time the surviving organisms or spores are recovered by 
agitation on a bed of glass beads in the presence of a neutraliser. Following 
neutralisation the number of surviving organisms or spores is determined employing 
the media and incubation conditions specified in the relevant standard.  The efficacy 
of the disinfectant is determined by comparison with a set of water controls treated in 
the same manner as the test surfaces. As with the suspension tests, a range of 
validations are performed including a neutralisation test which ensure the 
neutralisation solution is effective.  
The challenge posed by the standard suspension and surface tests was increased 
by increasing the amount of interfering substance (see below), reducing the contact 
time, employing a higher initial inoculum and changing the organism involved. The 
standard conditions and the relevant modifications are outlined in Table 1. Testing 
procedures and validations were performed as outlined in the relevant standards 
(BSI, 2008, BSI, 2001, BSI, 2002, BSI, 1997). Emphasis has been placed on shorter 
contact times than those specified in the standards, this reflects the need for a rapid 
disinfection impact to prevent cross contamination and the environmental survival 
pothogenic microorganisms.  Tests were carried out in triplicate, on separate days 
and were only considered valid if the relevant validations met the criteria specified in 
standards.   
The tests employed are all commonly used to verify the effectiveness of disinfectants 
employed in healthcare settings. Two testing approaches were employed; firstly 
suspension tests to determine basic bactericidal, (BS EN 1276(BSI, 1997)), 
fungicidal (BS EN 1650 (BSI, 2008)) and sporicidal (BS EN 13704 (BSI, 2002)) 
activity and secondly, surface tests (BS EN 13697(BSI, 2001)) to determine the 
surface bactericidal and sporicidal activity of the two disinfectants. In order to pass 
these standard tests a disinfectant has to generate the required log reduction in the 
specified contact time in the presence of the specified interfering substance (Table 
1). The organisms specified by the standards (BSI, 2006) are chosen to be 
representative of a wide range of pathogenic organisms relevant to healthcare 
settings. In suspension tests, a suspension of organisms or spores is mixed with a 
sample of interfering substance (see below) and then with the disinfectant under test. 
The mixture is then incubated at 20oC for the specified contact time (Table 1), 
following incubation a sample of the test mixture is transferred to a neutralisation 
solution which stops the action of the disinfectant and preserves the contact time. 
Following neutralisation the number of surviving organisms or spores is determined 
employing the media and incubation conditions specified in the relevant standard.  
The tests include a range of validations including a neutralisation test which ensure 
the neutralisation solution is effective.  
In the surface test BS EN 13697 (BSI, 2001) a suspension of bacteria or spores is 
mixed with a sample of interfering substance (see below) and then dried onto a 
stainless steel surface prior to the application of the disinfectant under test. Following 
the specified contact time the surviving organisms or spores are recovered by 
agitation on a bed of glass beads in the presence of a neutraliser. Following 
neutralisation the number of surviving organisms or spores is determined employing 
the media and incubation conditions specified in the relevant standard.  The efficacy 
of the disinfectant is determined by comparison with a set of water controls treated in 
the same manner as the test surfaces. As with the suspension tests, a range of 
validations are performed including a neutralisation test which ensure the 
neutralisation solution is effective.  
No attempt was made to simulate wiping; the aim being to evaluate the products in a 
“spray and wipe” configuration where the disinfection impact can be assessed free of 
the influence of mechanical action.  
Products 
The PAA generating powder blend (PB) (MTP Innovations Ltd, UK) was used at a 
range of concentrations (20, 10, 5 and 2.5 g/l) in standard hardness water (BSI, 
1997). Commercial NaDCC tablets were employed to generate solutions of 1000ppm 
and 10,000ppm FAC in standard hardness water (BSI, 1997) as per manufactures 
instructions, i.e. 1 tablet in 2.5 litres to generate 1000 ppm FAC and 4 tablets in 1.0 
litre to generate 10,000 ppm FAC. 
Interfering Substances  
Organic matter such as blood, serum, pus and faecal material (Russell, 2004), is 
commonly associated with microbial contamination. The presence of organic 
material may interfere with the action of disinfectants through either a direct reaction 
or via providing a protective environment for the microbes concerned(Russell, 2004). 
Consequently many biocide tests include the presence of interfering organic 
substances to reflect this potential impact. In this study three levels of interfering 
substance have been employed to provide an increasing level of challenge to 
disinfectant performance. These level: simulated clean, dirty (BSI, 1997) (0.3 g/l and 
3.0 g/l Bovine Serum albumin(BSA)) and enhanced dirty conditions(BSI, 2005) (3.0 
g/l BSA with 3 ml/l sheep erythrocytes) are all used in the European disinfection 
standards. Enhanced dirty conditions are taken from testing standards aimed at 
mycobactericidal activity where the presence of blood provides an additional level of 
organic challenges which may interfere with disinfectant activity.  
Determination of Peracetic Acid and Chlorine Concentrations 
 PAA and FAC concentrations were determined by iodometric titrations (Greenspan 
and MacKellar, 1948, Eaton et al., 2005). 
Organisms 
The organisms employed are those outlined in the relevant European standards. 
Bactericidal tests were carried out against Escherichia coli (NCIMB 8879), 
Enterococcus hirae  (NCIMB 8191), Pseudomonas aeruginosa (NCIMB 10421) and 
Staphylococcus aureus (NCIMB 9518). Fungicidal test were carried out against 
Aspergillus brasiliensis (ATCC 16404) (previously known as Aspergillus niger) and 
Candida albicans (ATCC 10231).  Bacillus subtilis (B. subtilis) (ATCC 6633) spores 
(109 spores/ml) were obtained from Raven Labs Ltd, USA. Spores of C. difficile 
(NCTC 13366) were recovered from Fastidious Anaerobe Agar (FAA) (Lab M Ltd), 
supplemented with Cycloserine/Cefoxitin (Lab M Ltd). C. difficile cultures were 
incubated anaerobically, at 37°C for 7 days. Prior to use, C. difficile spore 
suspensions were alcohol shocked (HPA, 2012) to remove vegetative cells. 
Generally, B. subtilis spores were preferred as a surrogate to C. difficile spores due 
to their purity, safety, reduced incubation times, economy of media and ease of 
dispersion.    
 
Results 
PAA and FAC Determination  
The full strength PB generated 2000 to 2500 ppm PAA (x̅ ≈ 2250 ppm) at a pH of 7.5 
to 8.5 after the 20 minute dwell time specified by the manufacturer.  The effect of 
increased dilution on PAA generation was not a linear relationship (Figure 1) with a 
50% reduction in powder loading generating an 18% reduction in PAA concentration.  
When prepared as per manufactures instructions the 1000 and 10,000 ppm FAC 
solutions were found to be on average 8% greater than specified by the 
manufacturers. The NaDCC tablets generated FAC at full strength immediately 
following dissolution, there was no generation curve evident. 
Suspension Tests 
Fungicidal and Yeasticidal Activity  
Under clean and dirty conditions the 2250 ppm PAA solution and the 1,000ppm FAC 
generated a >4 log reduction in Candida albicans in 15 minutes. When tested 
against Aspergillus brasiliensis under clean conditions the 2250 ppm PAA solution 
generated a much lower (<3.34±0.00) log reduction than 1000ppm FAC (4.34±0.04). 
At 10,000ppm FAC a >4 log reduction was seen in fungal spores under all 
conditions.  
Bactericidal Activity 
The 2250 ppm PAA solution and 1000ppm FAC demonstrated rapid bactericidal 
activity under enhanced dirty conditions generating a >5 log reduction for all strains 
within 30 seconds.  The PAA powder blend matched the performance of 1000ppm 
FAC at 30 seconds down to 700ppm PAA (5g/l).  
Sporicidal Activity 
When challenged with a 7 log (spores/ml)(Table 1) B. subtilis spore load only the 
2250 ppm PAA solution and 10,000ppm FAC demonstrated significant sporicidal 
activity (Figure 2). The influence of increased organic loading had a greater impact 
on the chlorine based disinfectants (Figure 2). For example under dirty and 
enhanced dirty conditions the PAA solution was able generate a complete log 
reduction within 5 minutes, whereas the 10,000 ppm FAC required 30 and 60 
minutes respectively to generate the same impact. When challenged with this 
increased spore load 1000 ppm FAC was unable to generate any significant impact 
even under simulated clean conditions. When challenged with the standard spore 
load (5 log spores/ml) PAA solutions remained sporicidal (BSI, 2002) (Table 2) down 
to 450 ppm under enhanced dirty conditions. When C. difficile was substituted for B. 
subtilis in BS EN 13704  (BSI, 2002)(Figure 3) PAA had superior sporicidal activity 
under dirty conditions and comparable activity under enhanced dirty conditions to 
10,000 ppm FAC.  
Surface Tests 
Bactericidal Activity 
Across all test strains (Table 1), the full strength PB (2250 ppm PAA) produced a >6 
log reduction under clean and dirty conditions. Under clean conditions 1000 ppm 
FAC produced a ≈3 log reduction for all bacterial strains, with no impact under dirty 
conditions. The performance of 10,000ppm FAC mirrored that of PAA under clean 
conditions, under dirty conditions the performance was 2-3 logs lower. 
Sporicidal Activity 
Across all organic loadings the full strength PB (2250 ppm PAA) generated >4 log 
reduction in B. subtilis spores within 3 minutes (Table 1), whereas 1000ppm FAC 
was unable to generate any significant reduction up to 5 minutes contact time (Table 
1). Similar performance was observed with 10,000ppm FAC suggesting that the 
drying of spores to the surface significantly reduced its sporicidal activity.  
Discussion 
Bactericidal activity of the PAA generating PB matched that of 1000 ppm FAC down 
to a loading generating 700 ppm PAA even under enhanced dirty conditions. 
Increasing the organic challenge had a limited impact on the performance of PAA 
when compared to 10,000 ppm FAC. The impact of organic soil was most 
pronounced during surface tests where the drying of soil, bacteria and spores onto 
surfaces significantly reduced the performance of 10,000 ppm FAC when compared 
to PAA (Table 1).  
The only case where FAC was seen to be more effective than PAA was the 
treatment of filamentous fungi. There is evidence from the literature that levels of 
PAA in the region of 5000 ppm is required for the effective treatment of Aspergillus 
niger (Niknejad et al., 2011, Sisti et al., 2012) which is above that generated by the 
powder blend investigated. This data and the literature data (Niknejad et al., 2011, 
Sisti et al., 2012) suggests that Aspergillus niger spores are specifically resistant to 
PAA based disinfectants. This may be due to the hydrophobic nature of Aspergillus 
niger spores(Whitehead et al., 2011).  
Overall the results suggest that PAA generating PBs provide a suitable substitute in 
situations where 1000 and 10,000 ppm of FAC are recommended(DoH and HPA, 
2009, Pratt et al., 2007). In particular these disinfectants are suited to applications 
where there is significant organic soil and sporicidal activity is required, due to its 
relative insensitivity to organic soil. Where antifungal activity is a specific 
requirement, then chlorine generating products appear to be more effective with 
higher levels of PAA being needed to generate significant fungicidal activity.  
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1276 1650 13704 13697 
Standard Additional Standard Addition
al Standard Additional Standard Additional 
Organisms 
E. coli 
E.hirae 
S. aureus 
P.aeruginosa 
N/A 
A. 
brasiliensis  
C. albicans 
N/A B. subtilis C. difficile 
E. coli 
E.hirae 
S. aureus 
P.aeruginosa 
B. subtilis 
(Spores) 
Interfering 
Substances 
Clean & 
Dirty 
Enhanced 
Dirty 
Clean & 
Dirty 
N/A 
Clean & 
Dirty 
Enhanced 
Dirty 
Clean & 
Dirty 
Enhanced 
Dirty 
Contact Time 5 Min 30 Sec 
upwards 15 Min N/A 
60 
Minutes 
30 Sec 
upwards 5 Minutes 
30 Sec 
upwards 
Bacterial / 
Fungal/ 
Spore 
Challenge 
107 cfu/ml N/A 106 cfu/ml N/A 105 cfu/ml 10
8 cfu/ml 
B. subtilis 
106 cfu/ 
surface 
105 cfu/ 
surface 
Pass Criteria 
(Log 
Reduction) 
5 N/A 4 N/A 3 N/A 
4 (Bacteria) 
3 (Fungi) 
N/A 
 
Table1. Modifications to Standard Tests 
Product 
Loading (g/l) Conditions Pass/Fail 
Time to Required to Generate a 3 Log 
Reduction* (Minutes) 
20 Enhanced Dirty Pass 0.5 
10 
Dirty Pass 0.5 
Enhanced Dirty Pass 5 
5 
Dirty Pass 5 
Enhanced Dirty Pass 15 
2.5 
Clean Pass 30 
Dirty Pass 30 
Enhanced Dirty Fail >60 
*A 3 Log reduction in spores is the pass criteria for the BS EN 13704 sporicidal standard test.  
Table 2. Sporicidal Activity at Reduced PAA Levels 
 
 
Time 
(min) 
Log reduction in Bacillus subtilis spores ± standard deviation 
DIFFX 1,000ppm available chlorine 10,000ppm available chlorine 
0.3gl-1 
BSA 
3gl-1 
BSA 
3gl-1 BSA 
3% sheep 
erythrocytes 
0.3gl-1 
BSA 
3gl-1 
BSA 
3gl-1 BSA 
3% sheep 
erythrocytes 
0.3gl-1 
BSA 
3gl-1 
BSA 
3gl-1 BSA 
3% sheep 
erythrocytes 
0.5 0.34± 0.06 
0.41±
0.08 1.35±0.23 
0.01± 
0.02 
0.01± 
0.04 * 
0.19±
0.23 
0.02± 
0.05 0.22±0.11 
1.5 1.79± 0.03 
1.81±
0.04 1.63±0.42 
0.07± 
0.01 
0.05± 
0.06 * 
0.31±
0.19 
0.14± 
0.09 0.35±0.11 
3 4.73± 0.04 
4.76±
0.03 4.20±0.09 
0.18± 
0.10 
0.13± 
0.04 * 
0.37±
0.22 
0.17± 
0.06 0.51±0.12 
5 4.73± 0.04 
4.76±
0.03 4.20±0.09 
0.20± 
0.08 
0.39± 
0.31 * 
0.52±
0.20 
0.39± 
0.04 0.78±0.13 
Note: *, indicates no data due to poor performance at lower level of interference 
Table 1. Sporicidal Surface Tests 
Figure 1. Impact of Product Loading on Peracetic Acid Generation
Figure 2. Sporicidal Kill Time Assay
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Figure 3. Sporicidal Activity Against 
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